LHC Group (NASDAQ: LHCG) and R1 RCM (OTCMKTS:ACHI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitabiliy, risk, earnings, analyst recommendations, institutional ownership and valuation.

Earnings and Valuation

This table compares LHC Group and R1 RCM’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
LHC Group $926.33 million 1.25 $85.92 million $2.16 29.37
R1 RCM N/A N/A N/A $0.64 4.02

LHC Group has higher revenue and earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than LHC Group, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for LHC Group and R1 RCM, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LHC Group 0 0 7 0 3.00
R1 RCM 0 0 0 0 N/A

LHC Group presently has a consensus target price of $65.14, indicating a potential upside of 2.70%. Given LHC Group’s higher possible upside, analysts plainly believe LHC Group is more favorable than R1 RCM.

Insider & Institutional Ownership

84.6% of LHC Group shares are owned by institutional investors. Comparatively, 7.0% of R1 RCM shares are owned by institutional investors. 14.8% of LHC Group shares are owned by company insiders. Comparatively, 59.8% of R1 RCM shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares LHC Group and R1 RCM’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LHC Group 4.09% 9.48% 6.04%
R1 RCM -9.55% -128.00% -8.69%

Risk & Volatility

LHC Group has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, R1 RCM has a beta of -0.55, meaning that its share price is 155% less volatile than the S&P 500.

Summary

LHC Group beats R1 RCM on 9 of the 10 factors compared between the two stocks.

About LHC Group

LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, and emotional and spiritual support. Its community-based service operations offer a range of services to patients in their home or in a medical facility. The services range from assistance with grooming, medication reminders and meal preparation. It provides facility-based services principally through its LTACHs.

About R1 RCM

R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company’s PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.